The corporate team at Penningtons Manches Cooper has advised Seloxium on the completion of its spin-out from Oxford University and initial seed funding led by Oxford Science Enterprises in cooperation with Oxford University Innovation, the university’s technology transfer office.
Seloxium is developing its multi-patented ‘selective flocculation’ technology, called SelectalTM, to change the way valuable metallic resources are mined, refined, recycled, and processed. The technology helps businesses obtain high-purity metals from their waste or process streams and achieve their sustainability goals by removing toxic metals from their wastewater.
The Penningtons Manches Cooper team advising Seloxium was led by corporate partner James Went with corporate senior associate Lindsay Chadwick and included support from IP partner Chris Shelley, commercial managing associate Edmund Forey and employment senior associate Victoria Spires.
Dr Christian Peters, a co-founder, and Seloxium’s chief executive officer said: “I am very excited that Seloxium is helping change the way we reclaim, process and recycle critically important metals in a more efficient and environmentally responsible way. I’m grateful to James Went and the Penningtons Manches Cooper team for their help in this important step forward for Seloxium.”
James Went, corporate partner at Penningtons Manches Cooper said: “We are delighted to have advised Seloxium on their spin-out from Oxford University and initial seed funding. Their work is addressing critical environmental challenges and we look forward to continuing to support them on their journey.”
The team at Penningtons Manches Cooper specialises in advising innovative technology companies, particularly those focused on solving global sustainability issues, on all aspects of their legal needs, having advised on a number of significant transactions in this area in the last 12 months including - Bramble Energy on their Series B fundraising, First Light Fusion, who recently achieved a world first fusion result, on their Series C fundraising and moa Technology on their Series B fundraising.